Episodes
Monday Nov 18, 2024
ACR24 -Day3b
Monday Nov 18, 2024
Monday Nov 18, 2024
Best Things I Saw Today in PsA:Dr. Catherine Bakewell
Do TNFis and JAKis Prevent Cancer!?:Dr. Richard Conway
Efficacy and Safety of Nipocalimab for Sjogren's Syndrome:Dr. Mike Putman
Evaluating ANA Patterns and Titers with AI:Dr. Bella Mehta
Improvements in Pain and Fatigue in Bimekizumab:Dr. Philip Mease
Long Term Follow up from APIPPRA:Dr. Antoni Chan talks with Dr. Andrew Cope
Race Neutral PFTs in Scleroderma Improves Equity:Dr. Caoilfhionn Connolly talks with Dr. Kamini Kuchinad
Summary of JAKi Studies:Dr. Peter Nash
The Psoriatic March: PsA before PsO:DR. Antoni Chan
Use of AI in Hand Ultrasound Scoring:Dr. Bella Mehta
What is MCTD? The Great Debate:Drs. Caoilfhionn Connolly & Lisa Christopher-Stine
What's The State of Biosimilars?:Drs. Eric Dein and Jonathan Kay
Pred Softly: Steroids:Dr. Jiha Lee talks with Dr. Beth Wallace
Monday Nov 18, 2024
ACR24 - Day3a
Monday Nov 18, 2024
Monday Nov 18, 2024
Control RA, Build Stronger Bones:Dr. Jiha Lee talks with Dr. Rachel Elam
Hold or continue JAKi and IL-17 when receiving COVID boosters?:Dr. Bella Mehta
Long-term Safety Profile of Bimekizumab in axSpA and PsA:Dr. Philip Mease
Navigating Rheumatology Care in Humanitarian Crisis Settings:Dr. Antoni Chan talks with Dr. Martha Dhzhus
RA Roundup: Is LDA Inappropriate? What about Statins for JAKs?:Dr. Eric Dein
Sex Differences in Psoriatic Arthritis:Dr. Catherine Bakewell
Single v Double Lung Transplants for Disease-related ILD:Dr. Eric Dein talks with Dr. Harry Hurley
Sonelokimab in PsA: Phase 2 Data:Dr. Philip Mease
Treating SpA:Dr. Marina Magrey
Monday Nov 18, 2024
ACR24 - Day2d
Monday Nov 18, 2024
Monday Nov 18, 2024
Assessment of axSpA:Dr. Antoni Chan
Defining Difficult to Manage axSpA:Dr. Lihi
DISH in SpA:Dr. Sheila Reyes
Generative AI in Rheumatology: The Good, The Bad, The Ugly:Dr. Akhil Sood
Native Americans with RA Die Young:Dr. Eric Dein
Precision Immunotherapy in Axial SpA:Dr. Marina Magrey
When, What and How Long to Treat GCA & PMR:Dr. Janet Pope
Monday Nov 18, 2024
ACR24 - Day2c
Monday Nov 18, 2024
Monday Nov 18, 2024
A Fibroblast Renaissance:Dr. Andrea Fava
A useful urinary biomarker for lupus nephritis:Dr. Andrea Fava
ACR Advocacy Update:Dr. Eric Dein talks with Dr. Christina Downey, ACR Government Affairs Committee, and Dr. Kaitlyn Brittan, RheumPAC
Carotid Doppler Ultrasound Screening in Axial SpA:Dr. Trish Harkins discussed with Dr. Barry O'Shea
Enhanced Detection of Myocarditis in Idiopathic Inflammatory
Myopathies:Dr. Caoilfhionn Connolly talks with Dr. Julie Paik
PsA: Impact of Sex:Dr. Arthur Kavanaugh
Rethinking Lupus Care: Early Biologics, Less Steroids:Dr. Akhil
Treatment Considerations for RA-ILD:Dr. Jeff Sparks with Dr. Scott Matson
Monday Nov 18, 2024
ACR24 Daily Recap Day2
Monday Nov 18, 2024
Monday Nov 18, 2024
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care.
Join us live and stay at the forefront of rheumatology!
Sunday Nov 17, 2024
ACR24 - Day2b
Sunday Nov 17, 2024
Sunday Nov 17, 2024
JAKi Studies at ACR:Dr. Peter Nash
Palliative Care in Rheumatology:Dr. Jiha Lee talks with Dr. Shannon Herndon
Estimating Inflammation, Damage and Patient Distress:Dr. Jack Cush talks with Dr. Ted Pincus
Methotrexate and the Gut Microbiome:Dr. Jonathan Kay talks with Dr. Rebecca Blank
Poly-treatment of Polymyalgia Rheumatica?:Dr. Janet Pope
Predicting Flares in Rheumatoid Arthritis:Dr. Jonathan Kay interviews Dr. John Isaacs
"Changing Mindsets about Methotrexate Side Effects":Dr. Mrinalini Dey
Biologic Monotherapy vs Combination with cDMARDs in PsA:Dr. Adela Castro
Cyclophosphomide vs Mycophenolate vs Tacrolimus in Lupus Nephritis:Dr. Mike Putman
ANA+ and no Autoimmune Disease? Check the liver:Dr. Janet Pope
SELECTing the right patients: upadacitinib in GCA:Dr. Brian Jaros
Neuropsychiatric Lupus: The Forgotten Symptoms:Dr. Mrinalini Dey talks with Dr. Chris Wincup
Sunday Nov 17, 2024
ACR24 - Day2a
Sunday Nov 17, 2024
Sunday Nov 17, 2024
Bimekizumab in PsA Showed Sustained Reductions in Disease Impact:Dr. Eric Dein talks with Dr. Ana-Marie Orbai
CAR-T Therapy and Lupus:Dr. Akhil Sood talks with Dr. Chris Wincup
Cycling vs Switching after TNFi Failure in axSpA:Dr. Lihi Eder
Difficult to manage AxSpA:Dr. Sheila Reyes talks with Dr. Denis Poddubnyy
Gender Differences in AxSpA:Dr. Adela Castro
Metabolic Dysregulation and RA Interstitial Lung Disease:Dr. Mrinalini Dey
PsA Ultrasound Updates:Dr. Catherine Bakewell and Dr. Lihi Eder
SELECT-GCA: Efficacy and Safety of Upadacitinib:Dr. Richard Conway
Sunday Nov 17, 2024
RheumNow Day 1 Recap ACR Convergence 2024 Highlights
Sunday Nov 17, 2024
Sunday Nov 17, 2024
Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care.
Join us live and stay at the forefront of rheumatology!
Saturday Nov 16, 2024
ACR24 - Day1c
Saturday Nov 16, 2024
Saturday Nov 16, 2024
Aging Gracefully in Managing Rheumatic Diseases:Dr. Mrinalini Dey interviews Dr. Elena Myasoedova
Apremilast Benefits and Risks in PsA:Dr. Akhil Sood
Assessing ASAS Criteria: CLASSIC Study Results:Dr. Adela Castro
Assessment and management of axSpA:Dr. Antoni Chan
Disease Activity in RA-ILD:Dr. Richard Conway
Finding the Right Combination Therapy in RA:Dr. Jonathan Kay interviews Dr. Ernest Choy
Highlights in axSpA:Dr. Marina Magrey
Hot Topics in axSpA:Dr. Marina Magrey
Proposed ACR Guidance for Use of MSUS in Psoriatic Arthritis:Dr.
Antoni Chan interviews Dr. Catherine Bakewell
PsA Potpourri:Dr. Arthur Kavanaugh
RA Treatment Adherence: Is decision making really shared?:Dr. Jonathan
Kay interviews Dr. Cécile Gaujoux-Viala
RA: One JAK to Rule Them All?:Dr. Brian Jaros
What is a Positive MRI in Spondyloarthritis?:Dr. Sheila Reyes interviews Dr. Walter Maksymowych
Saturday Nov 16, 2024
ACR24 - Day1b
Saturday Nov 16, 2024
Saturday Nov 16, 2024
JAK-pot! How fast do DMARDs work?:Dr. Mike Putman and Dr. Kim Lauper
Paraoxonase-1: Possible Biomarker for Progression to RA:Dr. Jonathan Kay
Potential Impact of Weight Loss Drugs in Rheumatic Diseases:Dr. Arthur Kavanaugh
PREDICT-SpA: Evaluating the influence of gender on disease assessment tools:Dr. Sheila Reyes
SELECT-GCA: Upadacitinib in Giant Cell Arteritis:Dr. Mike Putman
Too Many CAR-Ts for Horses?:Dr. Pope
Transplant-free Survival Predictors in Idiopathic Inflammatory Myopathies-ILD:Dr. Gaby Martinez